Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression

Abstract

Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are known to interact with several transcription factors and regulate their transcriptional activities. The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein activates transcription from its long terminal repeat (LTR) through interaction with cellular factors such as CREB and a transcriptional coactivator CBP/p300. However, little is known about the interaction between Tax and transcriptional repressors. Here, we demonstrate the physical and functional interaction between Tax and HDAC1. We found that HDAC1 represses the trans-activation function of Tax in 293T and MT4 cells. However, this repression was restored by treatment with an HDAC inhibitor, Trichostatin A. We also observed physical interaction between Tax and HDAC1 both in vitro and in vivo. The N-terminal region of HDAC1 (amino acid residues 28–97) was required for this binding. Moreover, HDAC1 inhibited the synergistic trans-activation of Tax observed on ectopic expression of CBP. However, this repression was relieved by overexpression of CBP. Thus, HDAC1 is likely to compete with CBP in binding with Tax and functions as a negative regulator for the transcriptional activation by Tax.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akagi T, Ono H, Nyunoya H, Shimotohno K . 1997 Oncogene 14: 2071–2078

  • Ariumi Y, Kaida A, Lin JY, Hirota M, Masui O, Yamaoka S, Taya Y, Shimotohno K . 2000 Oncogene 19: 1491–1499

  • Ariumi Y, Kaida A, Hatanaka M, Shimotohno K . 2001 Biochem. Biophys. Res. Commun. 287: 556–561

  • Billin AN, Thirlwell H, Ayer DE . 2000 Mol. Cell. Biol. 20: 6882–6890

  • Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1999 EMBO J. 18: 2449–2458

  • Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601

  • Colgin MA, Nyborg JK . 1998 J. Virol. 72: 9396–9399

  • Gwack Y, Byun H, Hwang S, Lin C, Choe J . 2001 J. Virol. 75: 1909–1917

  • Jeang KT, Widen SG, Semmes OJ, Wilson SH . 1990 Science 247: 1082–1084

  • Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Li YS, Wu CW . 2000 J. Biol. Chem. 275: 20436–20443

  • Kihara-Negishi F, Yamamoto H, Suzuki M, Yamada T, Sakurai T, Tamura T, Oikawa T . 2001 Oncogene 20: 6039–6047

  • Knoepfler PS, Eisenman RN . 1999 Cell 99: 447–450

  • Krithivas A, Young DB, Liao G, Greene D, Hayward SD . 2000 J. Virol. 74: 9637–9645

  • Kwok RP, Laurance ME, Goldman PS, Shin H, Connor LM, Marriott SJ, Goodman RH . 1996 Nature 380: 642–646

  • Lemasson I, Robert-Hebmann V, Hamaia S, Duc DM, Gazzolo L, Devaux C . 1997 J. Virol. 71: 1975–1983

  • Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T . 2000 EMBO J. 19: 662–671

  • Marzio G, Wagener C, Gutierrez MI, Cartwright P, Herin K, Giacca M . 2000 J. Biol. Chem. 275: 10887–10892

  • Nichot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G . 2000 Oncogene 19: 2155–2164

  • Punga T, Akusjärvi G . 2000 FEBS Lett. 476: 248–252

  • Robertson KD . 2001 Oncogene 20: 3139–3155

  • Rountree MR, Bachman KE, Herman JG, Baylin SB . 2001 Oncogene 20: 3156–3165

  • Saggioro D, Forino M, Chieco-Bianchi L . 1991 Virology 182: 68–75

  • Soutoglou E, Katrakili N, Talianidis I . 2000 Mol. Cell 5: 745–751

  • Suzuki T, Narita T, Uchida-Toita M, Yoshida M . 1999 Virology 259: 384–391

  • Uchiyama T . 1997 Annu. Rev. Immunol. 15: 15–37

  • Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T, Hatanaka M . 1996 EMBO J. 15: 873–887

  • Yang SH, Vickers E, Brehm A, Kouzarides T, Sharrocks AD . 2001 Mol. Cell. Biol. 21: 2801–2814

  • Yoshida M, Horinouchi S, Beppu T . 1995 BioEssays 17: 423–430

  • Yoshida M . 2001 Annu. Rev. Immunol. 19: 475–496

  • Zhong H, May MJ, Jimi E, Ghosh S . 2002 Mol. Cell 9: 625–636

Download references

Acknowledgements

We thank Dr T Kouzarides for providing pcDNA3-HD1F, Dr M Hatanaka for pH2R-Tax, Dr I Talianidis for CMV-CBP and Dr Y Namba for anti-Tax mAb MI73. We also thank Dr M Hijikata, Dr T Ohshima and Mr A Kaida for helpful discussion, and Ms N Umehara and Ms JY Lin for helping our work. This work was supported by Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kunitada Shimotohno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ego, T., Ariumi, Y. & Shimotohno, K. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 21, 7241–7246 (2002). https://doi.org/10.1038/sj.onc.1205701

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205701

Keywords

This article is cited by

Search

Quick links